Food News and Research

RSS

Gene study could pave way for novel methods for plagues and other infectious diseases

An international consortium of scientists, including Universitat Aut-noma de Barcelona (UAB) researcher Deodoro Oliveira, have sequenced the genome of three species of parasitoid wasps of the genus Nasonia.

18 Feb 2010

FDA issues Complete Response Letter for Horizant in treatment of RLS

GlaxoSmithKline and XenoPort, Inc. Wednesday received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets, an investigational non-dopaminergic treatment for moderate-to-severe primary Restless Legs Syndrome (RLS).

18 Feb 2010

Eriez unveils new Dual-Beam X-Ray and Metal Detector systems for improved food safety

Eriez®, world authority in magnetic, vibratory and inspection applications, has introduced an extra wide combination E-Z Tec® Dual-Beam Multi-Zone X-Ray and Metal Detector System.

18 Feb 2010

FDA warns about drug mix-ups; drug maker agrees to name change to avoid confusion

The U.S. Food and Drug Administration today warned consumers about the potential for serious side effects from mistakenly using Maalox Total Relief instead of other Maalox products. The two products are intended for the relief of different symptoms and contain different active ingredients.

18 Feb 2010

PDA emphasizes the importance of developing healthy teeth and gums at early age

It's National Children's Dental Health Month, an oral health campaign designed to educate children about the importance of good oral health. The Pennsylvania Dental Association emphasizes developing good habits at an early age to help children get a good start on a lifetime of healthy teeth and gums.

18 Feb 2010

Program for healthcare writing opportunities

With ever-rising healthcare spending, writing opportunities about the health and wellness industry are unlimited. “Regardless of economic conditions, writers will always have lots of topics to cover,” says Sherry Shameer Cohen, President of the Connecticut Press Club.

18 Feb 2010

Javelin Pharmaceuticals’ Dyloject NDA receives FDA PDUFA date

Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that its New Drug Application (NDA) submitted on December 2, 2009 to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, has received an FDA PDUFA date of October 3, 2010. This NDA review is in support of US marketing approval and registration of Dyloject for the management of acute moderate-to-severe pain in adults.

18 Feb 2010

Calif. budget cuts would end aid to new legal immigrants; Minn. Dems criticize Pawlenty for relying on federal funds

Gov. Arnold Schwarzenegger's latest proposals to close California's budget shortfall would end public assistance for most new legal immigrants, eliminating emergency cash, food and medical aid for those who don't yet qualify for federal welfare. The proposal would represent an about-face for the state.

17 Feb 2010

New sugar-based polymer for disposing food packaging and other plastic items

Food packaging and other disposable plastic items could soon be composted at home along with organic waste thanks to a new sugar-based polymer.

17 Feb 2010

Eat fruits and vegetables to prevent heart disease

As heart disease continues to be the leading cause of death in the United States for all adults, a new report released by the Nutrilite Health Institute, America's Phytonutrient Report: Heart Health by Color*, shows that Americans are falling short on heart-healthy phytonutrients.

17 Feb 2010

Health Canada approves Talecris Biotherapeutics' PROLASTIN-C for AAT deficiency

Talecris Biotherapeutics announced today that it has received approval from Health Canada for PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]), a more purified and concentrated version of PROLASTIN® produced using advances in manufacturing technology. A similar approval for PROLASTIN-C was granted by the U.S. Food and Drug Administration on October 17, 2009.

17 Feb 2010

FDA clears Otonomy's IND for clinical trial of OTO-104 in Meniere's disease patients

Otonomy, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of OTO-104 in patients with Meniere's disease, a debilitating disorder of the inner ear affecting balance and hearing.

17 Feb 2010

NMT Medical completes private placement of common stock and warrants for $5.8M

NMT Medical, Inc. today announced that it has completed a private placement of its common stock and warrants to purchase additional shares of common stock to existing and new stockholders for aggregate proceeds of approximately $5.8 million.

17 Feb 2010

Cipher Pharmaceuticals announces fourth-quarter and fiscal year 2009 results

Cipher Pharmaceuticals Inc. today announced its financial and operational results for the fourth quarter and fiscal year ended December 31, 2009.

17 Feb 2010

Walgreen acquires Duane Reade for total enterprise value of $1.075 billion

Walgreen Co. and New York-based drugstore chain Duane Reade Holdings, Inc. today announced a definitive agreement under which Walgreens will acquire Duane Reade from affiliates of Oak Hill Capital Partners in a cash transaction for a total enterprise value of $1.075 billion, which includes the assumption of debt.

17 Feb 2010

SynCardia Total Artificial Heart recipient celebrates 10 years of life

On Feb. 22, Bill Wohl, a former recipient of the SynCardia temporary CardioWest™ Total Artificial Heart, will celebrate 10 years of enjoying life to the fullest with the donor heart he received at University Medical Center on Feb. 22, 2000.

17 Feb 2010

AHF to protest Merck’s Isentress pricing and policies at CROI

AIDS Healthcare Foundation (AHF) will host a protest Wednesday morning, February 17 at 8:00am targeting Merck and Co. Pharmaceuticals over the pricing and policies for its key HIV/AIDS drug, Isentress, the most expensive first-line AIDS treatment in the US, during the 17th Conference of Retroviruses and Opportunistic Infections (CROI) in San Francisco.

17 Feb 2010

Purdue officials report double-digit increases in research funding

Richard O. Buckius, Purdue's vice president for research, reported a record $342.2 million in sponsored research programs for fiscal year 2008-09. That represents an 18 percent increase in federal support and a 2.2 percent increase in industry research support from the previous year.

17 Feb 2010

Researchers find food safety violations in independently owned ethnic restaurants in Kansas

In a study of independently owned restaurants in 14 Kansas counties, Kansas State University researchers found a significantly higher number of food safety violations in ethnic restaurants than in nonethnic restaurants. The next step for their research is to understand the reasons for these differences and to work alongside restaurant operators to remedy the problems.

17 Feb 2010